Literature DB >> 14762164

Inducible, reversible, and stable RNA interference in mammalian cells.

Sunita Gupta1, Rebecca A Schoer, James E Egan, Gregory J Hannon, Vivek Mittal.   

Abstract

RNA interference is a powerful genetic approach for efficiently silencing target genes. The existing method of gene suppression by the constitutive expression of short hairpin RNAs (shRNAs) allows analysis of the consequences of stably silencing genes but limits the analysis of genes essential for cell survival, cell cycle regulation, and cell development. We have developed an inducible U6 promoter for synthesis of shRNAs in both human and murine cells. Cells containing stably integrated shRNA expression constructs demonstrate stringent dosage- and time-dependent kinetics of induction with undetectable background expression in the absence of the inducer ecdysone. Inducible suppression of human p53 in glioblastoma cells shows striking morphological changes and defects in cell cycle arrest caused by DNA damage, as expected. Remarkably, the inducibility is reversible after withdrawal of the inducer, as observed by reappearance of the protein and a restoration of the original cell phenotype. Inducible and reversible regulation of RNA interference has broad applications in the areas of mammalian genetics and molecular therapeutics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14762164      PMCID: PMC357029          DOI: 10.1073/pnas.0306111101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action.

Authors:  J Gil; M Esteban
Journal:  Apoptosis       Date:  2000-04       Impact factor: 4.677

2.  Argonaute2, a link between genetic and biochemical analyses of RNAi.

Authors:  S M Hammond; S Boettcher; A A Caudy; R Kobayashi; G J Hannon
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

3.  Combined sequential treatment with interferon and dsRNA abrogates virus resistance to interferon action.

Authors:  P I Marcus; M J Sekellick
Journal:  J Interferon Cytokine Res       Date:  2001-06       Impact factor: 2.607

4.  An RNA-dependent RNA polymerase gene in Arabidopsis is required for posttranscriptional gene silencing mediated by a transgene but not by a virus.

Authors:  T Dalmay; A Hamilton; S Rudd; S Angell; D C Baulcombe
Journal:  Cell       Date:  2000-05-26       Impact factor: 41.582

5.  A system for stable expression of short interfering RNAs in mammalian cells.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Science       Date:  2002-03-21       Impact factor: 47.728

6.  Role for a bidentate ribonuclease in the initiation step of RNA interference.

Authors:  E Bernstein; A A Caudy; S M Hammond; G J Hannon
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

Review 7.  Regulation of the G2/M transition by p53.

Authors:  W R Taylor; G R Stark
Journal:  Oncogene       Date:  2001-04-05       Impact factor: 9.867

8.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

9.  Development of an inducible pol III transcription system essentially requiring a mutated form of the TATA-binding protein.

Authors:  W Meissner; H Rothfels; B Schäfer; K Seifart
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

10.  p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells.

Authors:  Y Hirose; M S Berger; R O Pieper
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

View more
  61 in total

1.  A versatile single-plasmid system for tissue-specific and inducible control of gene expression in transgenic mice.

Authors:  Jae-Kyun Ko; Kyoung-Han Choi; Xiaoli Zhao; Shinji Komazaki; Zui Pan; Noah Weisleder; Jianjie Ma
Journal:  FASEB J       Date:  2011-04-25       Impact factor: 5.191

2.  Inducible suppression of Fgfr2 and Survivin in ES cells using a combination of the RNA interference (RNAi) and the Cre-LoxP system.

Authors:  Xavier Coumoul; Wenmei Li; Rui-Hong Wang; Chuxia Deng
Journal:  Nucleic Acids Res       Date:  2004-06-15       Impact factor: 16.971

Review 3.  Optimizing RNA interference for application in mammalian cells.

Authors:  René H Medema
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

4.  Genes required for Drosophila nervous system development identified by RNA interference.

Authors:  Andrej I Ivanov; Alessandra C Rovescalli; Paola Pozzi; Siuk Yoo; Brian Mozer; Hsi-Ping Li; Shu-Hua Yu; Haruhiro Higashida; Vicky Guo; Michael Spencer; Marshall Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-08       Impact factor: 11.205

5.  Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape.

Authors:  Joshua N Leonard; David V Schaffer
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  The NIT1 promoter allows inducible and reversible silencing of centrin in Chlamydomonas reinhardtii.

Authors:  Bettina Koblenz; Karl-Ferdinand Lechtreck
Journal:  Eukaryot Cell       Date:  2005-11

7.  Differential gene silencing induced by short interfering RNA in cultured pine cells associates with the cell cycle phase.

Authors:  Wei Tang; Ronald J Newton; Douglas A Weidner
Journal:  Planta       Date:  2005-12-09       Impact factor: 4.116

8.  An inducible T7 RNA polymerase-dependent plasmid system.

Authors:  Matthias Hamdorf; Heide Muckenfuss; Ulrich Tschulena; Stephan Pleschka; Ralf Sanzenbacher; Klaus Cichutek; Egbert Flory
Journal:  Mol Biotechnol       Date:  2006-05       Impact factor: 2.695

9.  Reversal of adriamycin resistance in human mammary cancer cells by small interfering RNA of MDR1 and MDR3 genes.

Authors:  Lan Xiao; Rui Gao; Shi Lu; Lirong Ren; Zehua Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

Review 10.  RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA?

Authors:  Sandesh Subramanya; Sang-Soo Kim; N Manjunath; Premlata Shankar
Journal:  Expert Opin Biol Ther       Date:  2010-02       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.